Oncocytic variant of papillary thyroid carcinoma associated with Hashimoto's thyroiditis: A case report and review of the literature

Diagnostic Cytopathology

Volumn 37, Issue 8, 2009, Pages 600-606

  Lee, John ^a   Hasteh, Farnaz ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

Fine needle aspiration; Hashimoto's thyroiditis; H rthle cells; Oncocytic variant; Papillary thyroid carcinoma

Indexed keywords

LEVOTHYROXINE;

ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER CELL; CASE REPORT; CYTODIAGNOSIS; CYTOPATHOLOGY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; HASHIMOTO DISEASE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHYROIDISM; LYMPHOCYTIC INFILTRATION; ONCOCYTOMA; PAPANICOLAOU TEST; PAPILLARY CARCINOMA; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID MASS; THYROID PARAFOLLICULAR CELL; THYROIDECTOMY;

BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; FEMALE; HASHIMOTO DISEASE; HUMANS; MIDDLE AGED; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 67651005869     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21092     Document Type: Article

References (31)

1. Asa SL. My approach to oncocytic tumours of the thyroid. J Clin Pathol 2004;57:225-232.
2. Nesland JM, Sobrinho-Simoes M, Holm R, et al. Hürthle cell lesions of the thyroid: A combined study using transmission electron microscopy, scanning electron microscopy and immunocytochemistry. Ultrastruc Pathol 1985;8:131-142. (Pubitemid 16229797)
3. Sobrinho-Simoes M, Maximo v, Vieira de Castro I, et al. Hürthle (oncocytic) cell tumors of thyroid: Etiopathogenesis, diagnosis and clinical significance. Int J Surg Pathol 2005;13:29-35. (Pubitemid 40224094)
4. Montone KT, Baloch ZW, LiVolsi VA. The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: A surgical pathology and cytopathology review. Arch Pathol Lab Med 2008;132:1241-1250.
5. Maximo V, Soares P, Lima J, et al. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: A study with emphasis on Hürthle cell tumors. Am J Pathol 2002;160: 1857-1865. (Pubitemid 34525665)
6. DeMay RM. The art and science of cytopatholgy, volume II. In: DeMay RM, editor. Thyroid. Chicago: American Society for Clinical Pathology Press; 1996. p 703-778.
7. Berho M, Suster S. Clear nuclear changes in Hashimoto's thyroiditis. A clinicopathologic study of 12 cases Ann Clin Lab Sci 1995;25:513-521. 8. Weber D, Brinard J, Chen L. Atypical epithelial cells, cannot exclude papillary carcinoma, in fine needle aspiration of the thyroid. Acta Cytol 2008;52:320-324.
8. Rosai J. Rosai and Ackerman's Surgical pathology. 9th ed. In: Rosai J, editor. Thyroid gland. London: Mosby; 2004. p 515-594.
9. Elliott DD, Pitman MB, Bloom L, et al. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis. Cancer 2006;108: 102-109.
10. DeLellis RA, Lloyd RV, Heitz PU, et al. World Health Organization classification of tumours: Pathology and genetics of tumors of endocrine organs. In: DeLellis RA, Williams ED, editor. Tumours of the thyroid and parathyroid. Lyon: IARC Press; 2004. p 49-133.
11. Moreira AL, Waisman J, Cangiarella JF. Aspiration cytology of the oncocytic variant of papillary adenocarcinoma of the thyroid gland. Acta Cytol 2004;48:137-141. (Pubitemid 38381096)
12. Koseoglu RD, Onuk Filiz N. The oncocytic variant of papillary thyroid carcinoma. Turk J Med Sci 2006;36:387-392. (Pubitemid 44968961)
13. Berho M, Suster S. The oncocytic variant of papillary carcinoma of the thyroid: A clinicopathologic study of 15 cases. Hum Pathol 1997;28:47-53. (Pubitemid 27044481)
14. Sheils OM, O'Leary JJ, Uhlmann V, et al. RET/PTC-1 activation in Hashimoto thyroiditis. Int J Surg Pathol 2000;8:185-189.
15. Wirtschafter A, Schmidt R, Rosen D, et al. Expression of the RET/ PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope 1997;107:95-100. (Pubitemid 27045201)
16. Arif S, Blanes A, Diaz-Cano SJ. Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma. Histopath 2002; 41:357-362. (Pubitemid 35279034)
17. Prasad ML, Huang Y, Pellagata NS, et al. Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC. Histopath 2004;45: 39-46. (Pubitemid 38969560)
18. Abrosimov A, Saenko V, Meirmanov S, et al. The cytoplasmic expression of MUC1 in papillary thyroid carcinoma of different histological variants and its correlation with cyclin D1. Endocr Pathol 2007;18:68-75. (Pubitemid 47574989)
19. Trovisco V, Vieira-Castro I, Soares P, et al. BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol 2004;202:247-251. (Pubitemid 38208663)
20. Elisei R, Ugolini C, Viola D, et al. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study. J Clin Endocrinol Metab 2008;93:3943-3949.
21. Kebebew E, Weng J, Bauer J, et al. The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg 2007; 246:466-470. (Pubitemid 47312140)
22. Lupi C, Giannini R, Ugolini C. Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab 2007;92:4085-4090. (Pubitemid 350074715)
23. Kim TY, KimWB, Song JY, et al. The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma. Clin Endocrinol (Oxf) 2005;63:588-593. (Pubitemid 41626756)
24. Ito Y, Yoshida H, Maruo R, et al. BRAF mutation in papillary thyroid carcinoma in Japanese population: Its lack of correlation with high-risk clinicopathological features and disease-free survival in paitents. Endocr J 2009;56:89-97.
25. Gonzalez-Campora R, Herrero-Zapatero A, Lerma E, et al. Hürthle cell and mitochondrion-rich tumors: A clinicopathologic study. Cancer 1986;57:1154-1163. (Pubitemid 16166226)
26. Hedinger CE, Williams ED, Sobin LH. Histological typing of thyroid tumors. In: Hedinger CE, editor: International histological classification of tumours, vol 11. Berlin: Springer-Verlag; 1988.
27. Herrera MF, Hay ID, Wu PS, et al. Hurthle cell (oxyphilic) papillary thyroid carcinoma: A variant with more aggressive biologic behavior. World J Surg 1992;16:669-674.
28. Beckner ME, Heffess CS, Oertel JE. Oxyphilic papillary thyroid carcinomas. Am J Clin Pathol 1995;103:280-287.
29. Hill JH, Werkhaven JA, DeMay RM. Hurthle cell variant of papillary thyroid carcinoma of the thyroid gland. Otolaryngol Head Neck Surg 1988;98:338-341. (Pubitemid 18111652)
30. Apel RL, Asa S, LiVolsi VA. Papillary Hurthle cell carcinoma with lymphocytic stroma: "Warthin-like tumor" of the thyroid. Am J Surg Pathol 1995;19:810-814.
31. Baloch ZW, LiVolsi VA. Warthin-like papillary carcinoma of the thyroid. Arch Pathol Lab Med 2000;124:1192-1195.